The DOI matches its Crossref record.
Comprehensive review on additives of topical dosage forms for drug delivery
Open accessAbstract
Skin is the largest organ of the human body and plays the most important role in protecting against pathogen and foreign matter. Three important modes such as topical, regional and transdermal are widely used for delivery of various dosage forms. Among these modes, the topical dosage forms are preferred because it provides local therapeutic activity when applied to the skin or mucous membranes. Additives or pharmaceutical excipients (non-drug component of dosage form) are used as inactive ingredients in dosage form or tools for structuring dosage forms. The main use of topical dosage form additives are controling the extent of absorption, maintaining the viscosity, improving the stability as well as organoleptic property and increasing the bulk of the formulation. The overall goal of this article is to provide the clinician with information related to the topical dosage form additives and their current major applications against various diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 195
- 10.1016/j.ejpb.2012.06.006 · doi:10.1016/j.ejpb.2012.06.006
- 10.4137/OED.S3612 · doi:10.4137/oed.s3612
- 10.1166/jbn.2013.1569 · DOI
- 10.1016/j.ijpharm.2010.09.007 · doi:10.1016/j.ijpharm.2010.09.007
- 10.3109/10837450.2010.495394 · doi:10.3109/10837450.2010.495394
- 10.1208/s12248-008-9024-9 · DOI · Paper page
- 10.1111/j.1468-2494.2010.00633.x · DOI
- 10.1002/jps.22183 · DOI
- 10.1021/bm400898t · doi:10.1021/bm400898t
- 10.1046/j.1365-2133.2003.04950.x · doi:10.1046/j.1365-2133.2003.04950.x
- 10.1016/j.ijpharm.2012.07.074 · doi:10.1016/j.ijpharm.2012.07.074
- Asakawa M, 1989, Hinyokika Kiyo, 35, 39
- 10.4014/jmb.1202.02013 · doi:10.4014/jmb.1202.02013
- 10.1208/s12249-011-9661-7 · DOI
- 10.1016/j.mehy.2013.09.027 · DOI
- 10.1016/j.actatropica.2012.06.004 · DOI
- Belov SV, 2013, Med Tekh, 2, 20
- 10.3109/10837450.2013.763260 · DOI
- 10.4103/2230-973X.114896 · doi:10.4103/2230-973x.114896
- 10.1016/j.biomaterials.2013.09.073 · DOI
- Bikkad ML, 2013, J Liposome Res
- Birkenfeld B, 2011, Pol J Vet Sci, 14, 621, 10.2478/v10181-011-0092-x · doi:10.2478/v10181-011-0092-x
- 10.1016/j.oooo.2012.07.487 · DOI
- 10.1615/JEnvironPatholToxicolOncol.v26.i4.60 · doi:10.1615/jenvironpatholtoxicoloncol.v26.i4.60
- 10.1007/s00403-011-1130-3 · DOI
- 10.1016/S0005-2736(01)00369-8 · DOI · Paper page
- 10.1016/j.bbamem.2004.01.006 · DOI · Paper page
- 10.1177/096032719601500905 · doi:10.1177/096032719601500905
- 10.2166/wst.2013.013 · doi:10.2166/wst.2013.013
- 10.1016/j.jcis.2013.01.065 · DOI
- 10.1021/jp9006763 · DOI
- 10.1109/TBCAS.2009.2021769 · DOI
- 10.1016/j.actbio.2013.07.002 · DOI
- 10.1088/1758-5082/2/3/035004 · DOI · Paper page
- 10.1093/rheumatology/ket133 · DOI
- 10.1016/S0168-3659(03)00014-2 · doi:10.1016/s0168-3659(03)00014-2
- 10.1016/j.bbagen.2013.06.001 · doi:10.1016/j.bbagen.2013.06.001
- 10.1159/000018281 · doi:10.1159/000018281
- 10.1039/c3cc42596g · doi:10.1039/c3cc42596g
- Derry S, 2013, Cochrane Database Syst Rev, 2, CD007393
- 10.1016/j.ijpharm.2011.03.057 · DOI
- 10.1098/rsfs.2012.0090 · DOI
- 10.1016/j.jpedsurg.2011.08.014 · doi:10.1016/j.jpedsurg.2011.08.014
- 10.3109/10717544.2013.843610 · DOI
- 10.1016/j.exppara.2006.12.004 · DOI
- 10.1007/BF02849891 · DOI
- 10.1167/iovs.12-10717 · doi:10.1167/iovs.12-10717
- 10.1046/j.1365-2133.2002.04800.x · DOI
- 10.1213/ANE.0b013e3181cde5a5 · DOI
- 10.1016/j.ijbiomac.2013.03.008 · doi:10.1016/j.ijbiomac.2013.03.008
- 10.1097/00042737-199812000-00007 · doi:10.1097/00042737-199812000-00007
- 10.2165/11311020-000000000-00000 · doi:10.2165/11311020-000000000-00000
- 10.1111/j.1600-0536.2012.02161.x · doi:10.1111/j.1600-0536.2012.02161.x
- 10.1111/j.1439-0507.2012.02202.x · DOI
- 10.1016/j.ijpharm.2013.06.009 · DOI
- 10.1046/j.1365-4362.1999.00782.x · DOI
- 10.1371/journal.pone.0074404 · DOI
- 10.4103/0378-6323.62961 · doi:10.4103/0378-6323.62961
- 10.1615/CritRevTherDrugCarrierSyst.v29.i1.10 · DOI · Paper page
- 10.1615/CritRevTherDrugCarrierSyst.2013007259 · DOI
- 10.1140/epje/i2013-13030-3 · doi:10.1140/epje/i2013-13030-3
- 10.1208/s12249-013-0017-3 · DOI
- 10.1016/j.joen.2011.09.020 · DOI
- 10.3109/07388551.2012.672319 · doi:10.3109/07388551.2012.672319
- Gratieri T, 2013, Eur J Pharm Biopharm
- 10.1002/jps.21157 · DOI
- Gupta VD, 2012, Int J Pharm Compd, 16, 80
- 10.3109/03639045.2010.550299 · doi:10.3109/03639045.2010.550299
- 10.1080/09546630802513693 · doi:10.1080/09546630802513693
- Herzog J L, 2011, J Drugs Dermatol, 10, 853
- 10.1248/bpb.29.705 · DOI
- 10.1016/j.biortech.2011.06.049 · DOI
- 10.1016/j.ijsu.2013.06.842 · doi:10.1016/j.ijsu.2013.06.842
- 10.1248/cpb.58.611 · doi:10.1248/cpb.58.611
- 10.1023/A:1011911302005 · DOI
- Hussain Shah SN, 2013, Bioimpacts, 3, 11
- Iena Ia M, 1993, Lik Sprava, 2, 142
- Jain A, 2010, PDA J Pharm Sci Technol, 64, 517
- 10.1016/j.ijpharm.2013.05.032 · doi:10.1016/j.ijpharm.2013.05.032
- 10.3358/shokueishi.47.167 · doi:10.3358/shokueishi.47.167
- 10.1177/1091581811406987 · DOI
- 10.1007/s12272-012-0710-x · doi:10.1007/s12272-012-0710-x
- 10.1016/j.burns.2011.03.017 · DOI
- 10.3168/jds.2012-5942 · doi:10.3168/jds.2012-5942
- Khlamova OG, 2011, Antibiot Khimioter, 56, 34
- Khozeimeh F, 2010, J Contemp Dent Pract, 11, 017, 10.5005/jcdp-11-2-17 · DOI
- 10.1111/j.1365-2133.2009.09477.x · DOI
- Kircik L, 2010, J Drugs Dermatol, 9, 137
- 10.1128/JCM.01425-08 · DOI
- 10.1002/ptr.3509 · doi:10.1002/ptr.3509
- 10.1248/cpb.56.1384 · doi:10.1248/cpb.56.1384
- 10.3109/02713683.2010.542866 · doi:10.3109/02713683.2010.542866
- Lazareva EB, 2002, Antibiot Khimioter, 47, 9
- 10.1111/j.1365-2133.2009.09145.x · DOI
- 10.1016/j.ejpb.2012.05.011 · DOI
- 10.1159/000339652 · doi:10.1159/000339652
- 10.1002/cmdc.201200229 · DOI
- 10.1016/j.carbpol.2012.07.036 · DOI
- 10.1021/mp200558a · DOI
- 10.1111/nyas.12214 · DOI
- 10.3109/03639045.2012.691510 · DOI
- 10.3171/2013.6.SPINE1311 · doi:10.3171/2013.6.spine1311
- 10.3390/molecules16064672 · doi:10.3390/molecules16064672
- 10.1016/j.ijpharm.2013.06.081 · doi:10.1016/j.ijpharm.2013.06.081
- Menter A, 2008, Cutis, 81, 509
- 10.1111/j.1473-2165.2008.00405.x · DOI
- 10.3748/wjg.v18.i33.4563 · DOI
- 10.1016/S0944-7113(00)80084-7 · doi:10.1016/s0944-7113(00)80084-7
- 10.1016/j.ijpharm.2011.05.008 · DOI · Paper page
- 10.1016/j.colsurfb.2011.05.050 · DOI
- 10.1002/jbm.a.34702 · DOI
- 10.1007/s10856-012-4740-1 · doi:10.1007/s10856-012-4740-1
- 10.1016/S2221-1691(12)60096-3 · DOI
- 10.1097/SCS.0b013e3181f43f43 · DOI
- Naganathan S, 2010, Waste Manag Res, 28, 848, 10.1177/0734242X09355073 · doi:10.1177/0734242x09355073
- 10.1002/bdd.1866 · DOI
- 10.1002/jbm.b.31757 · doi:10.1002/jbm.b.31757
- 10.2165/11539780-000000000-00000 · doi:10.2165/11539780-000000000-00000
- 10.1016/j.ijbiomac.2012.12.008 · DOI · Paper page
- 10.1016/j.ijpharm.2011.07.034 · doi:10.1016/j.ijpharm.2011.07.034
- 10.1016/j.niox.2012.01.007 · DOI
- 10.2147/IJN.S40519 · DOI
- 10.1016/j.farmac.2004.04.006 · doi:10.1016/j.farmac.2004.04.006
- 10.1111/j.2041-1626.2012.00147.x · doi:10.1111/j.2041-1626.2012.00147.x
- 10.1067/mjd.2003.174 · DOI
- 10.1016/j.biortech.2013.02.061 · DOI
- 10.1111/jphp.12093 · DOI
- 10.1021/am400546x · doi:10.1021/am400546x
- Parnami N, 2013, Artif Cells Nanomed Biotechnol
- 10.1016/j.bpc.2010.03.015 · DOI
- 10.1080/09546630410023566 · doi:10.1080/09546630410023566
- 10.1016/j.ijpharm.2012.04.051 · DOI
- 10.1016/j.ejpb.2012.11.026 · DOI
- Puri R, 2012, Anticancer Drugs, 23, 923, 10.1097/CAD.0b013e3283534051 · doi:10.1097/cad.0b013e3283534051
- 10.1016/S1673-8527(07)60102-7 · DOI
- 10.1185/03007990802381364 · DOI
- 10.1007/s10928-006-9019-z · doi:10.1007/s10928-006-9019-z
- Rhoades J, 2013, J Appl Microbiol, 115, 987, 10.1111/jam.12302 · doi:10.1111/jam.12302
- Romantsov MG, 2009, Antibiot Khimioter, 54, 52
- 10.1111/j.1743-6109.2008.01118.x · DOI
- 10.4103/2230-973X.104397 · doi:10.4103/2230-973x.104397
- 10.1016/j.ejpb.2012.12.010 · DOI
- 10.3109/10837450.2013.819012 · doi:10.3109/10837450.2013.819012
- 10.1007/s00394-009-0042-x · DOI
- Sankar V, 2009, Pharmazie, 64, 731
- 10.1021/jp804176v · doi:10.1021/jp804176v
- 10.1093/bja/aen364 · DOI
- 10.1080/09593332508618434 · doi:10.1080/09593332508618434
- 10.1016/j.ijpharm.2010.10.036 · doi:10.1016/j.ijpharm.2010.10.036
- 10.1016/j.ijbiomac.2013.06.049 · doi:10.1016/j.ijbiomac.2013.06.049
- Shalonov PM, 1989, Klin Khir, 3, 53
- Shalviri A, 2011, J Pharm Pharm Sci, 14, 315, 10.18433/J38P4V · doi:10.18433/j38p4v
- Shatalov VN, 1988, Farmakol Toksikol, 51, 60
- 10.1248/yakushi.13-00004 · DOI
- 10.4103/2230-973X.107002 · doi:10.4103/2230-973x.107002
- 10.1208/s12249-009-9242-1 · doi:10.1208/s12249-009-9242-1
- Shul'diakov AA, 2012, Klin Med (Mosk), 90, 61
- Shul'diakov AA, 2012, Eksp Klin Farmakol, 75, 35
- 10.4155/tde.11.152 · doi:10.4155/tde.11.152
- 10.1073/pnas.1311355110 · DOI
- Soboleva LA, 2011, Eksp Klin Farmakol, 74, 41
- 10.1016/j.ctim.2012.05.001 · DOI
- 10.1016/j.saa.2012.05.088 · doi:10.1016/j.saa.2012.05.088
- Spraker MK, 2006, Cutis, 77, 113
- 10.1016/j.jaad.2005.04.029 · DOI
- 10.1016/S0966-6532(01)00077-4 · doi:10.1016/s0966-6532(01)00077-4
- Stough D, 2008, J Clin Aesthet Dermatol, 1, 16
- 10.1158/1940-6207.CAPR-09-0183 · doi:10.1158/1940-6207.capr-09-0183
- 10.1016/j.talanta.2006.07.046 · doi:10.1016/j.talanta.2006.07.046
- 10.1046/j.1365-2133.2001.04467.x · doi:10.1046/j.1365-2133.2001.04467.x
- 10.5021/ad.2013.25.1.5 · doi:10.5021/ad.2013.25.1.5
- 10.1111/j.1600-0846.2011.00600.x · doi:10.1111/j.1600-0846.2011.00600.x
- 10.3109/2000656X.2012.717897 · doi:10.3109/2000656x.2012.717897
- 10.1016/j.ejps.2012.12.014 · DOI
- 10.1016/j.ejps.2013.03.013 · DOI · Paper page
- 10.1016/j.nano.2012.05.008 · DOI
- 10.1159/000211405 · DOI
- 10.1208/s12249-012-9914-0 · DOI
- 10.4103/0975-1483.93570 · DOI
- 10.1016/j.actbio.2013.08.009 · doi:10.1016/j.actbio.2013.08.009
- 10.3748/wjg.v11.i45.7208 · doi:10.3748/wjg.v11.i45.7208
- 10.1080/09205063.2013.789357 · DOI
- 10.1615/CritRevTherDrugCarrierSyst.2013007362 · DOI
- 10.1016/j.ijpharm.2010.03.029 · DOI
- 10.1016/S0304-3940(03)00511-1 · DOI
- 10.1159/000029903 · doi:10.1159/000029903
- Wikiera A, 2013, Postepy Biochem, 59, 89
- 10.1002/jps.23548 · doi:10.1002/jps.23548
- 10.1016/S0168-3659(97)00143-0 · doi:10.1016/s0168-3659(97)00143-0
- 10.1166/jbn.2013.1555 · DOI
- Zhang YT, 2011, Int J Nanomedicine, 6, 2469
- 10.1016/j.msec.2013.06.034 · doi:10.1016/j.msec.2013.06.034
- 10.1002/jsfa.6146 · DOI
- Zivkovich AH, 2009, J Drugs Dermatol, 8, 570
- 10.1007/s00011-009-0065-z · DOI
Cited by
Permeation enhancer strategies in transdermal drug delivery
Marwah, H., Garg, T., Goyal, A. K., & Rath, G. (2016) · Drug Delivery · doi:10.3109/10717544.2014.935532 · Cited by 529
Self-citationA review on nanoparticle based treatment for wound healing
Rajendran, N. K., Kumar, S. S. D., Houreld, N. N., & Abrahamse, H. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.01.009 · Cited by 389
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 298
Advanced drug delivery approaches against periodontitis
Joshi, D., Garg, T., Goyal, A. K., & Rath, G. (2016) · Drug Delivery · doi:10.3109/10717544.2014.935531 · Cited by 257
Self-citationA Review of Moisturizers; History, Preparation, Characterization and Applications
Mawazi, S. M., Ann, J., Othman, N., Khan, J., Alolayan, S. O., Al thagfan, S. S., & Kaleemullah, M. (2022) · Cosmetics · doi:10.3390/cosmetics9030061 · Cited by 111
Metadata
- Authors
- Garg, T., Rath, G., & Goyal, A. K.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2014-01-23
- Volume
- 22
- Issue
- 8
- Pages
- 969-987
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W1966914419
- Cited by
- 161
- References
- 0
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comprehensive review on additives of topical dosage forms for drug delivery. https://app.cochat.ai/papers/10.3109/10717544.2013.879355
- The paper
- Garg, T., Rath, G., & Goyal, A. K. (2015). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Delivery. https://doi.org/10.3109/10717544.2013.879355
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.